Patents by Inventor Soo-Dong Woo

Soo-Dong Woo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11655482
    Abstract: Disclosed are a novel recombinant transition vector for increasing expression of a foreign protein in a native form without fusion partners, and a method for mass production of a foreign target protein using the same. The recombinant transition vector according to the present disclosure may allow a large amount of a foreign target protein with a high therapeutic and prophylactic value to be expressed in an insect cell. In particular, the vector may increase the expression of the foreign target protein in an own form thereof, not fused with other fusion partners. Therefore, the use of the recombinant transition vector may produce useful proteins such as antigens in insect cells at low cost and high efficiency.
    Type: Grant
    Filed: March 7, 2018
    Date of Patent: May 23, 2023
    Assignees: OPTIPHARM CO., LTD, CHUNGBUK NATIONAL UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION
    Inventors: Soo Dong Woo, Ji Hoon Lee, Won Seok Gwak, Ji In Ma, Beom Ku Han, Hyun Il Kim, Charl Se Park, Jae Bang Choi
  • Publication number: 20200291426
    Abstract: Disclosed are a novel recombinant transition vector for increasing expression of a foreign protein in a native form without fusion partners, and a method for mass production of a foreign target protein using the same. The recombinant transition vector according to the present disclosure may allow a large amount of a foreign target protein with a high therapeutic and prophylactic value to be expressed in an insect cell. In particular, the vector may increase the expression of the foreign target protein in an own form thereof, not fused with other fusion partners. Therefore, the use of the recombinant transition vector may produce useful proteins such as antigens in insect cells at low cost and high efficiency.
    Type: Application
    Filed: March 7, 2018
    Publication date: September 17, 2020
    Inventors: Soo Dong WOO, Ji Hoon LEE, Won Seok GWAK, Ji In MA, Beom Ku HAN, Hyun Il KIM, Charl Se PARK, Jae Bang CHOI
  • Patent number: 7514082
    Abstract: Disclosed are a novel virus suppressing factor (VSF) protein having antiviral activity against a variety of viruses and a hybridoma secreting such a VSF protein. In addition, the present invention discloses a pharmaceutical composition comprising the VSF protein for prevention or treatment of viral infections in humans and animals, and a method of preventing or treating viral infections using such a pharmaceutical composition. The VSF protein has strong antiviral activity against a variety of viruses.
    Type: Grant
    Filed: January 30, 2003
    Date of Patent: April 7, 2009
    Assignee: Immunemed, Inc.
    Inventors: Yoon-Won Kim, Young-Jin Kim, Yo-Han Choi, Jee-Yin Ahn, Soo-Dong Woo, Song-Woo Sin, Min-Kee Cho, Young-Hwan Byun, Jeung-Yul Kang
  • Publication number: 20050080236
    Abstract: Disclosed are a novel virus suppressing factor (VSF) protein having antiviral activity against a variety of viruses and a hybridoma secreting such a VSF protein. In addition, the present invention discloses a pharmaceutical composition comprising the VSF protein for prevention or treatment of viral infections in humans and animals, and a method of preventing or treating viral infections using such a pharmaceutical composition. The VSF protein has strong antiviral activity against a variety of viruses.
    Type: Application
    Filed: January 30, 2003
    Publication date: April 14, 2005
    Inventors: Yoon-Won Kim, Young-Jin Kim, Yo-Han Choi, Jee-Yin Ahn, Soo-Dong Woo, Song-Woo Sin, Min-Kee Cho, Young-Hwan Byun, Jeung-Yul Kang